Application of DCE-MRI in the Diagnosis of Brucellar Spondylitis
NCT ID: NCT02809625
Last Updated: 2023-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2016-03-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The disease can damage multiple systems including nervous system, circulatory system, reproductive system and bone joints, etc. The sooner the diagnosis of brucellar spondylitis is diagnosed and treated, the better will be the prognosis of the patients which can prevent the development of severe complications and diminish the need for surgical therapy. Thus the early diagnosis of brucellar spondylitis was of great significance.We quantitatively analyzed the brucellar spondylitis with DCE-MRI to explore the application of DCE-MRI in the early diagnosis of brucellar spondylitis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Radiomics Analysis Based on MRI to Detect Brucella Spondylitis
NCT06220500
Comparison of Sodium Fluoride Positron Emission Tomography and Magnetic Resonance Imaging of Spine and Sacroiliac Joints for Detection of Inflammatory Lesions in Spondyloarthritis Patients
NCT02869100
Magnetic Resonance Imaging and Ultrasonography in Evaluation of Muscle Diseases
NCT05692349
Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients
NCT00658060
Characterization and Differential Diagnosis of Vertebral Osteomyelitis
NCT01125839
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* low fever
* night sweats
* intermittent lower back pain
* movement limitation
Exclusion Criteria
35 Years
62 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Natural Science Foundation of China
OTHER_GOV
The Affiliated Hospital of Inner Mongolia Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peng fei Qiao, MD
Role: STUDY_DIRECTOR
The Affiliated Hospital of Inner Mongolia Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Affiliated Hospital of Inner Mongolia Medical University
Inner Mongolia, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AHInnerMongolia
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.